Ross\Johnson & Associates’s Palantir PLTR Stock Holding History

Ross\Johnson & Associates’s Portfolio PLTR Stock Details PLTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$817	Buy	7 +4	+133%	+$546	0.01%	104
2026 Q1	$439	Hold	3	–	–	0.01%	111
2025 Q4	$533	Hold	3	–	–	0.01%	148
2025 Q3	$547	Hold	3	–	–	0.01%	98
2025 Q2	$409	Hold	3	–	–	0.01%	113
2025 Q1	$253	Buy	+3	New	+$263	﹤0.01%	302

Other funds holding PLTR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ross\Johnson & Associates's PLTR Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Palantir (PLTR) stake by 133% in Q2 2026, buying an estimated $546 and bringing the position to 7 shares worth $817. The position accounts for 0.01% of the portfolio, ranked #104.

Ross\Johnson & Associates first reported a position in PLTR in Q1 2025 and has held it in 6 quarters since. 2,849 funds tracked by Wall St. Rank hold PLTR as of Q2 2026.

Ross\Johnson & Associates held 7 shares of Palantir worth $817 as of Q2 2026.
Ross\Johnson & Associates bought 4 Palantir shares in Q2 2026, an estimated $546.
Palantir made up 0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #104 holding.
Ross\Johnson & Associates first reported a position in Palantir in Q1 2025 and has held it in 6 quarters since.
2,849 funds tracked by Wall St. Rank held Palantir as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.